We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

142 hedge funds and large institutions have $1.17B invested in Amedisys in 2015 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 55 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

54% more capital invested

Capital invested by funds: $758M → $1.17B (+$408M)

22% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $13.2M

7% more funds holding

Funds holding: 133142 (+9)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 55

Holders
142
Holders Change
+9
Holders Change %
+6.77%
% of All Funds
3.83%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
22
Increased
48
Reduced
55
Closed
11
Calls
$16.1M
Puts
$13.2M
Net Calls
+$2.91M
Net Calls Change
-$1.04M
Name Holding Trade Value Shares
Change
Change in
Stake
CONA
151
Capital One National Association
New York
-$337K -12,571 Closed
Creative Planning
152
Creative Planning
Kansas
-$53K -1,964 Closed
PCM
153
Prelude Capital Management
New York
-$40K -1,500 Closed

AMED Hedge Fund Activity: Q2 2015 in Review

142 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2015, worth a combined $1.17B — up 54% from $758M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AMED positions and 11 closed out — a net gain of 11 holders — while 48 added to existing stakes and 55 trimmed.

The largest buyer was BlackRock Advisors, adding an estimated $11.2M. The largest seller was Millennium Management, cutting an estimated $7.16M.

  • 142 institutional investors held Amedisys (AMED) as of Q2 2015, up from 133 in Q1 2015.
  • Funds reported $1.17B of Amedisys stock for Q2 2015, up 54% quarter-over-quarter.
  • 22 funds opened new Amedisys positions in Q2 2015 and 11 closed out, a net change of +11 holders.
  • The largest Amedisys buyer in Q2 2015 was BlackRock Advisors, an estimated $11.2M added.
  • The largest Amedisys seller in Q2 2015 was Millennium Management, an estimated $7.16M sold.

Based on aggregated 13F filings for Q2 2015.